Your browser doesn't support javascript.
loading
Transcatheter Leadless Pacing in Children: A PACES Collaborative Study in the Real-World Setting.
Shah, Maully J; Borquez, Alejandro A; Cortez, Daniel; McCanta, Anthony C; De Filippo, Paolo; Whitehill, Robert D; Imundo, Jason R; Moore, Jeremy P; Sherwin, Elizabeth D; Howard, Taylor S; Rosenthal, Eric; Kertesz, Naomi J; Chang, Philip M; Madan, Nandini; Kutalek, Steven P; Hammond, Benjamin H; Janson, Christopher M; Ramesh Iyer, V; Williams, Matthew R.
Affiliation
  • Shah MJ; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia (M.J.S., C.M.J., V.R.I.).
  • Borquez AA; Department of Pediatrics, University of California, Rady Children's Hospital, San Diego (A.A.B., M.R.W.).
  • Cortez D; Department of Pediatrics, University of Minnesota, Minneapolis (D.C.).
  • McCanta AC; Department of Pediatrics, University of California, Davis, Sacramento (D.C).
  • De Filippo P; Department of Pediatrics, University of California, Children's Hospital of Orange County, Irvine (A.C.M.).
  • Whitehill RD; Cardiovascular Department, Ospedale Papa Giovanni XXIII Hospital, Bergamo, Italy (P.D.F.).
  • Imundo JR; Department of Pediatrics, Emory University, Children's Healthcare of Atlanta, GA (R.D.W.).
  • Moore JP; Department of Pediatrics, Penn State Health Children's Hospital, Hershey, PA (J.R.I.).
  • Sherwin ED; Department of Pediatrics, University of California, Los Angeles, Mattel Children's Hospital (J.P.M.).
  • Howard TS; Department of Pediatrics, George Washington University School of Medicine, Children's National Medical Center, DC (E.D.S.).
  • Rosenthal E; Department of Pediatrics, Baylor University, Texas Children's Hospital, Houston (T.S.H.).
  • Kertesz NJ; Evelina Children's Hospital, Guys & St Thomas' NHS Trust, London, United Kingdom (E.R.).
  • Chang PM; Department of Pediatrics, Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus (N.J.K.).
  • Madan N; Department of Pediatrics, University of Florida, Shands Children's Hospital, Gainesville (P.M.C.).
  • Kutalek SP; Department of Pediatrics, Drexel University College of Medicine, St. Christopher's Hospital of Children (N.M.).
  • Hammond BH; Department of Medicine, Drexel University College of Medicine, Philadelphia, PA (S.P.K.).
  • Janson CM; Department of Pediatrics, Lerner College of Medicine, Cleveland Clinic, OH (B.H.H.).
  • Ramesh Iyer V; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia (M.J.S., C.M.J., V.R.I.).
  • Williams MR; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia (M.J.S., C.M.J., V.R.I.).
Circ Arrhythm Electrophysiol ; 16(4): e011447, 2023 04.
Article in En | MEDLINE | ID: mdl-37039017
BACKGROUND: Transcatheter Leadless Pacemakers (TLP) are a safe and effective option for adults with pacing indications. These devices may be an alternative in pediatric patients and patients with congenital heart disease for whom repeated sternotomies, thoracotomies, or transvenous systems are unfavorable. However, exemption of children from clinical trials has created uncertainty over the indications, efficacy, and safety of TLP in the pediatric population. The objectives of this study are to evaluate clinical indications, procedural characteristics, electrical performance, and outcomes of TLP implantation in children. METHODS: Retrospective data were collected from patients enrolled in the Pediatric and Congenital Electrophysiology Society TLP registry involving 15 centers. Patients ≤21 years of age who underwent Micra (Medtronic Inc, Minneapolis, MN) TLP implantation and had follow-up of ≥1 week were included in the study. RESULTS: The device was successfully implanted in 62 of 63 registry patients (98%) at a mean age of 15±4.1 years and included 20 (32%) patients with congenital heart disease. The mean body weight at TLP implantation was 55±19 kg and included 8 patients ≤8 years of age and ≤30 kg in weight. TLP was implanted by femoral (n=55, 87%) and internal jugular (n=8, 12.6%) venous approaches. During a mean follow-up period of 9.5±5.3 months, there were 10 (16%) complications including one cardiac perforation/pericardial effusion, one nonocclusive femoral venous thrombus, and one retrieval and replacement of TLP due to high thresholds. There were no deaths, TLP infections, or device embolizations. Electrical parameters, including capture thresholds, R wave sensing, and pacing impedances, remained stable. CONCLUSIONS: Initial results from the Pediatric and Congenital Electrophysiology Society TLP registry demonstrated a high level of successful Micra device implants via femoral and internal venous jugular approaches with stable electrical parameters and infrequent major complications. Long-term prospective data are needed to confirm the reproducibility of these initial findings.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pacemaker, Artificial / Heart Defects, Congenital Type of study: Diagnostic_studies / Observational_studies Limits: Adolescent / Adult / Child / Humans / Newborn Language: En Journal: Circ Arrhythm Electrophysiol Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pacemaker, Artificial / Heart Defects, Congenital Type of study: Diagnostic_studies / Observational_studies Limits: Adolescent / Adult / Child / Humans / Newborn Language: En Journal: Circ Arrhythm Electrophysiol Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Type: Article